Rituximab intralesional en linfoma de anejos oculares

P. Crespo Robledo; M. J. Vázquez Castillo

doi:10.7399/fh.2014.38.4.7474

Rituximab intralesional en linfoma de anejos oculares

P. Crespo Robledo, M. J. Vázquez Castillo

Resumen

Palabras clave

Texto completo:

PDF

Referencias

Goda JS, Le LW, Lapperriere NJ, Millar B-A, Payne D, Gospodarowicz MK, et al. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys [Internet]. 2011 Nov 15 [citado 13-11-2013];81(4):e659–66. Disponible en: http://www.sciencedirect.com/science/journal/03603016/81

Seker M, Ozdemir B, Bilici A, Ustaalioğlu BB, Sonmez B, Yilmaz BE, et al. Bilateral conjunctival MALT lymphoma mimicking chronic conjunctivitis. Onkologie. 2010; 33(6):317–20.

Ferreri AJM, Ponzoni M, Martinelli G, Muti G, Guidoboni, Dolcetti R, Doglioni C. Rituximab in Patients with Mucosal-Associated Lymphoid Tissue-Type Lymphoma of the Ocular Adnexa. Haematologica [Internet]. 2005; 90(11):1578–79. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16266908

Lee S-B, Yang J-W, Kim C-S. The association between conjunctival MALT lymphoma and Helicobacter pylori. Br J Ophthalmol. 2008 Apr;92(4):534–6.

Ferreri AJM, Govi S, Pasini E, Mappa S, Bertoni F, Zaja F, et al. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol [Internet]. 2012 Aug 20 [citado el 13-11-2013];30(24):2988–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22802315

Savino G, Battendieri R, Balia L, Colucci D, Larocca LM, Laurenti L, et al. Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot study. Cancer Sci [Internet]. 2011 Aug [citado el 17-01-2014];102(8):1565–7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21564418

Ferreri AJM, Govi S, Colucci A, Crocchiolo R, Modorati G. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.Ophthalmology. 2011 Jan;118(1):24–8.

Savino G, Battendieri R, Gari M, Grazia Caputo C, Laurenti L, Blasi MA. Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections. J Cancer Res Clin Oncol. 2013. 139(4):1251–1255.

Stefanovic A, Lossos IS. Review article Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009;114(3):501–10.

DOI: http://dx.doi.org/10.7399%2Ffh.2014.38.4.7474